Biphasic Pancreatic Beta-Cell Stimulation for Insulin Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for insulin secretion from pancreatic beta cells are inefficient and do not effectively address the membrane potential decline with aging, leading to conditions like diabetes and arrhythmias.
Innovation Solution
Application of biphasic electrical current therapy, comprising anodal and cathodal stimulation, to increase the membrane potential of pancreatic beta cells, thereby enhancing insulin production and secretion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods for insulin secretion are used, then the process is simple, but the efficiency is low and does not address membrane potential decline with aging
Solution Approach 1:
The patent applies biphasic electrical current therapy that dynamically changes membrane potential parameters through alternating current phases. The first phase depolarizes the membrane potential to trigger insulin release, while the second phase repolarizes it to restore normal function. This parameter manipulation directly addresses the efficiency problem by leveraging electrical properties to enhance insulin production without complex mechanical devices.
Solution Approach 2:
The therapy employs periodic biphasic electrical pulses applied in alternating sequences. Each cycle consists of a depolarizing phase followed by a repolarizing phase, creating rhythmic electrical stimulation that continuously enhances insulin secretion. This periodic action maintains high productivity while keeping the device architecture relatively simple through repetitive waveform patterns.
2Productivity
If membrane potential is increased to enhance insulin production, then insulin secretion improves, but the risk of arrhythmias increases
Solution Approach 1:
The biphasic waveform alternates between depolarizing and repolarizing phases, creating a rhythmic pattern that stimulates insulin release while periodically restoring normal membrane potential. This periodic repolarization prevents sustained depolarization that would lead to arrhythmias, thus achieving high insulin secretion without excessive arrhythmia risk.
Solution Approach 2:
The therapy incorporates glucose sensing feedback that modulates the electrical stimulation intensity based on blood glucose levels. When glucose is high, the system applies stronger depolarizing phases to maximize insulin release. When glucose is normal or low, the stimulation intensity is reduced, preventing over-stimulation and arrhythmias. This feedback mechanism balances productivity with safety.
3Productivity
If electrical current therapy is applied to increase membrane potential, then insulin production increases, but energy consumption increases
Solution Approach 1:
The system optimizes energy usage by dynamically adjusting electrical parameters (amplitude, duration, frequency) based on real-time glucose levels and response. The biphasic waveform uses efficient current patterns that achieve maximum membrane potential change with minimum energy input, avoiding unnecessary energy consumption while maintaining high insulin production efficiency.
Solution Approach 2:
The feedback control system monitors glucose levels and adjusts stimulation intensity accordingly, applying electrical current only when and where needed. This prevents wasteful energy consumption during normal physiological states while ensuring sufficient stimulation when insulin production is required, optimizing the balance between productivity and energy use.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biphasic electrical current therapy effectively increases insulin production and secretion, potentially treating diabetes and improving the viability and function of pancreatic tissue for transplantation.
Implementation Method 1
application of biphasic electrical currents to the pancreas, responsive to glucose blood concentrations, in a way that controls the depolarization and repolarization of beta cells, thereby providing for controlled release of insulin
Data Source
AI summary
The present disclosure relates to a device for applying electrical stimulation to biological tissues. Specifically, the present disclosure is related to a device for applying anodal/cathodal biphasic electrical stimulation to beta cells of the pancreas. Through application of biphasic stimulation to beta cells of the pancreas, insulin secretion can be increased in an effort to overcome deficiencies associated with diabetic patients.